Tuesday, February 24, 2015 12:07:48 AM
Propanc has already completed pilot animal studies with great success:
PRP
Proven Anti- Tumor Activity in Mice
?? Anti-tumoractivityassessedinB- 16-F10 melanoma model.
? Treatment began 7 days post implant.
? Relative tumor volumes significantly smaller compared to control.
? PRPhasanti-tumoractivity,but without severe, or even serious side effects associated with chemotherapy.
FEATURED DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM